89 related articles for article (PubMed ID: 21071757)
1. Risk factors for progression of subclinical diabetic macular oedema.
Bhavsar KV; Subramanian ML
Br J Ophthalmol; 2011 May; 95(5):671-4. PubMed ID: 21071757
[TBL] [Abstract][Full Text] [Related]
2. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
[TBL] [Abstract][Full Text] [Related]
3. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
Nunes S; Ribeiro L; Lobo C; Cunha-Vaz J
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4595-604. PubMed ID: 23745006
[TBL] [Abstract][Full Text] [Related]
4. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
5. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.
Krepler K; Biowski R; Schrey S; Jandrasits K; Wedrich A
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):735-8. PubMed ID: 12271370
[TBL] [Abstract][Full Text] [Related]
6. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
Kim SJ; Equi R; Bressler NM
Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between macular morphology and visual function in diabetic macular edema].
Jin HY; Liu HY; Liu K; Sun XD; Ren QS; Xu X
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):524-7. PubMed ID: 23660322
[TBL] [Abstract][Full Text] [Related]
8. Expected value of foveal thickness in macular edema in Mexican patients with diabetes.
Lima-Gómez V; Razo Blanco-Hernández DM
Cir Cir; 2012; 80(2):109-14. PubMed ID: 22644004
[TBL] [Abstract][Full Text] [Related]
9. Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME.
Nunes S; Pereira I; Santos A; Bernardes R; Cunha-Vaz J
Br J Ophthalmol; 2010 Sep; 94(9):1201-4. PubMed ID: 20530184
[TBL] [Abstract][Full Text] [Related]
10. Retinal thickness study with optical coherence tomography in patients with diabetes.
Sánchez-Tocino H; Alvarez-Vidal A; Maldonado MJ; Moreno-Montañés J; García-Layana A
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1588-94. PubMed ID: 11980878
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
Yang XL; Zou HD; Xu X
Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
[TBL] [Abstract][Full Text] [Related]
12. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Macular Edema as a Predictor of Progression to Central-Involved Macular Edema in Type 2 Diabetes.
Lobo C; Pires I; Alves D; Pappuru R; Ribeiro L; Cunha-Vaz J
Ophthalmic Res; 2018; 60(1):18-22. PubMed ID: 29510401
[TBL] [Abstract][Full Text] [Related]
15. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
Browning DJ; Fraser CM; Clark S
Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
[TBL] [Abstract][Full Text] [Related]
16. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
17. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
[TBL] [Abstract][Full Text] [Related]
19. Association of serum lipids with macular thickness and volume in type 2 diabetes without diabetic macular edema.
Sasaki M; Kawashima M; Kawasaki R; Uchida A; Koto T; Shinoda H; Tsubota K; Wang JJ; Ozawa Y
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1749-53. PubMed ID: 24569581
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
